I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 26 studies | 27% ± 10% | |
| plasma cell | 22 studies | 48% ± 23% | |
| CD16-positive, CD56-dim natural killer cell, human | 14 studies | 31% ± 10% | |
| CD16-negative, CD56-bright natural killer cell, human | 12 studies | 26% ± 8% | |
| plasmablast | 11 studies | 63% ± 19% | |
| B cell | 9 studies | 29% ± 8% | |
| ciliated cell | 8 studies | 25% ± 7% | |
| IgG plasma cell | 8 studies | 36% ± 15% | |
| astrocyte | 8 studies | 36% ± 20% | |
| precursor B cell | 6 studies | 64% ± 13% | |
| T cell | 6 studies | 30% ± 9% | |
| mature NK T cell | 5 studies | 27% ± 7% | |
| IgA plasma cell | 5 studies | 41% ± 20% | |
| pro-B cell | 5 studies | 51% ± 13% | |
| immature B cell | 5 studies | 38% ± 13% | |
| CD8-positive, alpha-beta T cell | 5 studies | 30% ± 10% | |
| CD4-positive, alpha-beta T cell | 4 studies | 25% ± 10% | |
| pericyte | 4 studies | 26% ± 5% | |
| gamma-delta T cell | 4 studies | 25% ± 14% | |
| exhausted T cell | 3 studies | 29% ± 9% | |
| germinal center B cell | 3 studies | 34% ± 8% | |
| IgM plasma cell | 3 studies | 44% ± 5% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 24% ± 11% | |
| plasmacytoid dendritic cell | 3 studies | 20% ± 4% |
